Medical Devices & Implant

LuX-Valve Plus Approved for Hong Kong-Macao Medicine and Equipment Connect

Through this access pathway, LuX-Valve Plus is expected to initially meet the urgent and substantial treatment needs of patients suffering from tricuspid regurgitation (TR) in the region...

Starkey Unveils Omega AI Breakthrough in Hearing Technology

Omega AI represents Starkey's next major step toward transforming the hearing experience for patients worldwide...

Enovis completes sale of Dr. Comfort Footcare Solutions business

This divestiture, along with other initiatives already underway, positions Enovis to expand margins, enhance profitability, and accelerate debt reduction...

Thermo Fisher Scientific Introduces Molecular Microscope Diagnostic System

New gene expression profiling test enhances precision in assessing lung transplant rejection and injury...

Olympus launches SecureFlex, a Single-use Fine Needle Biopsy Device

Designed for use with an ultrasound endoscope, SecureFlex supports endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) ...

Czech Innovation against Alzheimer's: H2 Global Group Enters Key Growth Phase

H2 Global Group, together with its subsidiary H2 Medical Technologies, has entered a decisive growth stage following strong recognition at LSI Europe 2025 in London...

OMRON Healthcare Exceeds 400M Blood Pressure Monitors Sold

This landmark achievement underscores the company's longstanding commitment to extending healthy life expectancy by advancing home blood pressure monitoring and preventive cardiovascular care...

Zimmer Biomet Announces Japan PMDA Approval of Iodine-Treated Total Hip Replacement System

iTaperloc Complete and iG7 Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant surface to help address the issue of Periprosthetic Joint Infection after total joint replacement...

Nexalin Technology Announces Issuance of U.S. Patent Covering HALO Clarity Device Featuring DIFS Technology

The newly issued patent strengthens Nexalin’s expanding intellectual property estate, supporting the Company’s DIFS platform and ongoing clinical and regulatory initiatives...

Femasys Accelerates European Growth for FemBloc with Kebomed Partnership

Femasys leverages Kebomed’s pan-European distribution strength to drive the adoption of FemBloc permanent birth control in France and Benelux, unlocking significant market access...